Next Financial Group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Next Financial Group’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$7K	Hold	160	–	–	﹤0.01%	2340
2021 Q3	$8K	Hold	160	–	–	﹤0.01%	2115
2021 Q2	$8K	Hold	160	–	–	﹤0.01%	2081
2021 Q1	$8K	Hold	160	–	–	﹤0.01%	1972
2020 Q4	$8K	Hold	160	–	–	﹤0.01%	1860
2020 Q3	$7K	Buy	+160	New	+$7.01K	﹤0.01%	1756
2020 Q2	–	Sell	-160	Closed	-$6K	–	1911
2020 Q1	$6K	Hold	160	–	–	﹤0.01%	1676
2019 Q4	$7K	Hold	160	–	–	﹤0.01%	1893
2019 Q3	$6K	Hold	160	–	–	﹤0.01%	1879
2019 Q2	$6K	Sell	160 -9,340	-98%	-$367K	﹤0.01%	1851
2019 Q1	$395K	Buy	9,500 +9,340	+5,838%	+$380K	0.1%	160
2018 Q4	$6K	Hold	160	–	–	﹤0.01%	1519
2018 Q3	$8K	Buy	+160	New	+$7.58K	﹤0.01%	1066
2017 Q4	–	Sell	-160	Closed	-$7K	–	1446
2017 Q3	$7K	Hold	160	–	–	﹤0.01%	1342
2017 Q2	$7K	Hold	160	–	–	﹤0.01%	1463
2017 Q1	$7K	Sell	160 -5,895	-97%	-$240K	﹤0.01%	1421
2016 Q4	$237K	Sell	6,055 -1,237	-17%	-$50.3K	0.04%	424
2016 Q3	$322K	Buy	7,292 +3,221	+79%	+$146K	0.06%	336
2016 Q2	$170K	Sell	4,071 -99	-2%	-$4.19K	0.05%	332
2016 Q1	$167K	Buy	4,170 +2,497	+149%	+$106K	0.06%	318
2015 Q4	$85K	Sell	1,673 -677	-29%	-$34.5K	0.03%	467
2015 Q3	$110K	Sell	2,350 -2,706	-54%	-$163K	0.04%	407
2015 Q2	$315K	Buy	5,056 +580	+13%	+$36.1K	0.11%	202
2015 Q1	$276K	Buy	4,476 +900	+25%	+$53.4K	0.09%	242
2014 Q4	$193K	Sell	3,576 -526	-13%	-$28.7K	0.06%	312
2014 Q3	$217K	Buy	4,102 +3,682	+877%	+$187K	0.04%	433
2014 Q2	$20K	Buy	+420	New	+$20.3K	0.01%	604

Other funds holding XPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Centaurus Financial Anaheim, California $2.1B AUM 21.28% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Next Financial Group's XPH Position: Q4 2021 in Review

Next Financial Group held its State Street SPDR S&P Pharmaceuticals ETF (XPH) position steady in Q4 2021 at 160 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #2340.

Next Financial Group first reported a position in XPH in Q2 2014 and has held it in 27 quarters since. The position peaked at $395K in Q1 2019. 78 funds tracked by Wall St. Rank hold XPH as of Q4 2021.

Next Financial Group held 160 shares of State Street SPDR S&P Pharmaceuticals ETF worth $7K as of Q4 2021.
Next Financial Group left its State Street SPDR S&P Pharmaceuticals ETF share count unchanged in Q4 2021.
State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2340 holding.
Next Financial Group first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2014 and has held it in 27 quarters since.
Next Financial Group's State Street SPDR S&P Pharmaceuticals ETF position peaked at $395K in Q1 2019.
78 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.